ABBOTT LABORATORIES Operating Income
ABBOTT LABORATORIES (ABT) reported Operating Income of $1.34 billion for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-04-29
- ABBOTT LABORATORIES operating income (loss) for the quarter ending 2026-03-31 was $1.34B, a 20.56% decline year-over-year.
- ABBOTT LABORATORIES operating income (loss) for the quarter ending 2025-12-31 was $2.25B, a 17.79% increase year-over-year.
- ABBOTT LABORATORIES operating income (loss) for the quarter ending 2025-09-30 was $2.06B, a 10.65% increase year-over-year.
- ABBOTT LABORATORIES operating income (loss) for the quarter ending 2025-06-30 was $2.05B, a 22.95% increase year-over-year.
- ABBOTT LABORATORIES operating income (loss) for fiscal 2025 was $8.05B, a 17.99% increase from fiscal 2024.
- ABBOTT LABORATORIES operating income (loss) for fiscal 2024 was $6.83B, a 5.36% increase from fiscal 2023.
- ABBOTT LABORATORIES operating income (loss) for fiscal 2023 was $6.48B, a 22.53% decline from fiscal 2022.
- ABBOTT LABORATORIES operating income (loss) for fiscal 2022 was $8.36B, a 0.75% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $1.34B 10-Q · filed 2026-04-29 | $3.60B derived: sum of 2 quarters · filed 2026-04-29 | $5.65B derived: sum of 3 quarters · filed 2026-04-29 | $7.71B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | $2.25B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $4.31B derived: sum of 2 quarters · filed 2026-02-20 | $6.36B derived: sum of 3 quarters · filed 2026-02-20 | $8.05B 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | $2.06B 10-Q · filed 2025-10-29 | $4.11B derived: sum of 2 quarters · filed 2025-10-29 | $5.80B 10-Q · filed 2025-10-29 | $7.71B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | $2.05B 10-Q · filed 2025-07-30 | $3.75B 10-Q · filed 2025-07-30 | $5.66B derived: sum of 3 quarters · filed 2026-04-29 | $7.51B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | $1.69B 10-Q · filed 2026-04-29 | $3.60B derived: sum of 2 quarters · filed 2026-04-29 | $5.46B derived: sum of 3 quarters · filed 2026-04-29 | $7.13B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $1.91B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $3.77B derived: sum of 2 quarters · filed 2026-02-20 | $5.44B derived: sum of 3 quarters · filed 2026-02-20 | $6.83B 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | $1.86B 10-Q · filed 2025-10-29 | $3.53B derived: sum of 2 quarters · filed 2025-10-29 | $4.91B 10-Q · filed 2025-10-29 | $6.69B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-06-30 | $1.67B 10-Q · filed 2025-07-30 | $3.06B 10-Q · filed 2025-07-30 | $4.83B derived: sum of 3 quarters · filed 2026-02-20 | $6.48B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-03-31 | $1.39B 10-Q · filed 2025-04-30 | $3.17B derived: sum of 2 quarters · filed 2026-02-20 | $4.81B derived: sum of 3 quarters · filed 2026-02-20 | $6.36B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2023-12-31 | $1.78B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $3.43B derived: sum of 2 quarters · filed 2026-02-20 | $4.97B derived: sum of 3 quarters · filed 2026-02-20 | $6.48B 10-K · filed 2026-02-20 | ||||
| 2023-09-30 | $1.65B 10-Q · filed 2024-10-31 | $3.19B derived: sum of 2 quarters · filed 2024-10-31 | $4.70B 10-Q · filed 2024-10-31 | $6.00B derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | $1.54B 10-Q · filed 2024-07-31 | $3.05B 10-Q · filed 2024-07-31 | $4.36B derived: sum of 3 quarters · filed 2025-02-21 | $6.13B derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | $1.51B 10-Q · filed 2024-05-02 | $2.81B derived: sum of 2 quarters · filed 2025-02-21 | $4.58B derived: sum of 3 quarters · filed 2025-02-21 | $6.96B derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | $1.30B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $3.07B derived: sum of 2 quarters · filed 2025-02-21 | $5.45B derived: sum of 3 quarters · filed 2025-02-21 | $8.36B 10-K · filed 2025-02-21 | ||||
| 2022-09-30 | $1.77B 10-Q · filed 2023-11-01 | $4.15B derived: sum of 2 quarters · filed 2023-11-01 | $7.06B 10-Q · filed 2023-11-01 | $9.44B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-06-30 | $2.38B 10-Q · filed 2023-08-03 | $5.29B 10-Q · filed 2023-08-03 | $7.67B derived: sum of 3 quarters · filed 2024-02-16 | $10.21B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-03-31 | $2.91B 10-Q · filed 2023-05-04 | $5.29B derived: sum of 2 quarters · filed 2024-02-16 | $7.84B derived: sum of 3 quarters · filed 2024-02-16 | $9.23B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2021-12-31 | $2.38B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $4.92B derived: sum of 2 quarters · filed 2024-02-16 | $6.32B derived: sum of 3 quarters · filed 2024-02-16 | $8.43B 10-K · filed 2024-02-16 | ||||
| 2021-09-30 | $2.55B 10-Q · filed 2022-11-01 | $3.94B derived: sum of 2 quarters · filed 2022-11-01 | $6.05B 10-Q · filed 2022-11-01 | $8.48B derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-06-30 | $1.39B 10-Q · filed 2022-08-02 | $3.50B 10-Q · filed 2022-08-02 | $5.93B derived: sum of 3 quarters · filed 2023-02-17 | $7.43B derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-03-31 | $2.11B 10-Q · filed 2022-05-03 | $4.54B derived: sum of 2 quarters · filed 2023-02-17 | $6.04B derived: sum of 3 quarters · filed 2023-02-17 | $6.71B derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2020-12-31 | $2.43B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $3.93B derived: sum of 2 quarters · filed 2023-02-17 | $4.60B derived: sum of 3 quarters · filed 2023-02-17 | $5.36B 10-K · filed 2023-02-17 | ||||
| 2020-09-30 | $1.50B 10-Q · filed 2021-11-03 | $2.17B derived: sum of 2 quarters · filed 2021-11-03 | $2.92B 10-Q · filed 2021-11-03 | $4.31B derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-06-30 | $672.00M 10-Q · filed 2021-08-04 | $1.43B 10-Q · filed 2021-08-04 | $2.82B derived: sum of 3 quarters · filed 2022-02-18 | $4.02B derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-03-31 | $758.00M 10-Q · filed 2021-05-05 | $2.15B derived: sum of 2 quarters · filed 2022-02-18 | $3.35B derived: sum of 3 quarters · filed 2022-02-18 | $4.55B derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2019-12-31 | $1.39B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $2.59B derived: sum of 2 quarters · filed 2022-02-18 | $3.79B derived: sum of 3 quarters · filed 2022-02-18 | $4.53B 10-K · filed 2022-02-18 | ||||
| 2019-09-30 | $1.20B 10-Q · filed 2020-11-04 | $2.40B derived: sum of 2 quarters · filed 2020-11-04 | $3.14B 10-Q · filed 2020-11-04 | $4.31B derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | $1.21B 10-Q · filed 2020-07-29 | $1.95B 10-Q · filed 2020-07-29 | $3.11B derived: sum of 3 quarters · filed 2021-02-19 | $4.11B derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | $739.00M 10-Q · filed 2020-04-29 | $1.90B derived: sum of 2 quarters · filed 2021-02-19 | $2.90B derived: sum of 3 quarters · filed 2021-02-19 | $3.78B derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | $1.17B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $2.16B derived: sum of 2 quarters · filed 2021-02-19 | $3.04B derived: sum of 3 quarters · filed 2021-02-19 | $3.65B 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $995.00M 10-Q · filed 2019-10-31 | $1.88B derived: sum of 2 quarters · filed 2019-10-31 | $2.48B 10-Q · filed 2019-10-31 | $3.14B derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-06-30 | $882.00M 10-Q · filed 2019-07-31 | $1.49B 10-Q · filed 2019-07-31 | $2.14B derived: sum of 3 quarters · filed 2020-02-21 | $2.91B derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-03-31 | $608.00M 10-Q · filed 2019-05-01 | $1.26B derived: sum of 2 quarters · filed 2020-02-21 | $2.03B derived: sum of 3 quarters · filed 2020-02-21 | $2.41B derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | $651.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $1.42B derived: sum of 2 quarters · filed 2020-02-21 | $1.81B derived: sum of 3 quarters · filed 2020-02-21 | $1.56B 10-K · filed 2020-02-21 | $1.73B 10-K · filed 2018-02-16 | |||
| 2017-09-30 | $769.00M 10-Q · filed 2018-10-31 | $810.00M 10-Q · filed 2017-11-02 | $1.16B derived: sum of 2 quarters · filed 2018-10-31 | $913.00M 10-Q · filed 2018-10-31 | $1.03B 10-Q · filed 2017-11-02 | $1.70B derived: sum of 4 quarters · filed 2019-02-22 | ||
| 2017-06-30 | $386.00M 10-Q · filed 2018-08-01 | $427.00M 10-Q · filed 2017-08-02 | $144.00M 10-Q · filed 2018-08-01 | $225.00M 10-Q · filed 2017-08-02 | $933.00M derived: sum of 3 quarters · filed 2019-02-22 | $1.83B derived: sum of 4 quarters · filed 2019-02-22 | ||
| 2017-03-31 | -$242.00M 10-Q · filed 2018-05-02 | -$202.00M 10-Q · filed 2017-05-03 | $547.00M derived: sum of 2 quarters · filed 2019-02-22 | $1.44B derived: sum of 3 quarters · filed 2019-02-22 | $2.26B derived: sum of 4 quarters · filed 2019-02-22 | |||
| 2016-12-31 | $789.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $1.69B derived: sum of 2 quarters · filed 2019-02-22 | $2.50B derived: sum of 3 quarters · filed 2019-02-22 | $3.03B 10-K · filed 2019-02-22 | $3.19B 10-K · filed 2017-02-17 | |||
| 2016-09-30 | $897.00M 10-Q · filed 2017-11-02 | $1.71B derived: sum of 2 quarters · filed 2017-11-02 | $2.24B 10-Q · filed 2017-11-02 | $3.05B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-06-30 | $816.00M 10-Q · filed 2017-08-02 | $1.34B 10-Q · filed 2017-08-02 | $2.15B derived: sum of 3 quarters · filed 2018-02-16 | $2.87B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-03-31 | $524.00M 10-Q · filed 2017-05-03 | $1.34B derived: sum of 2 quarters · filed 2018-02-16 | $2.05B derived: sum of 3 quarters · filed 2018-02-16 | $2.78B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2015-12-31 | $815.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $1.53B derived: sum of 2 quarters · filed 2018-02-16 | $2.26B derived: sum of 3 quarters · filed 2018-02-16 | $2.87B 10-K · filed 2018-02-16 | ||||
| 2015-09-30 | $713.00M 10-Q · filed 2016-11-03 | $1.44B derived: sum of 2 quarters · filed 2016-11-03 | $2.05B 10-Q · filed 2016-11-03 | $2.88B derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | $729.00M 10-Q · filed 2016-08-03 | $1.34B 10-Q · filed 2016-08-03 | $2.17B derived: sum of 3 quarters · filed 2017-02-17 | $2.90B derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | $610.00M 10-Q · filed 2016-05-04 | $1.44B derived: sum of 2 quarters · filed 2017-02-17 | $2.17B derived: sum of 3 quarters · filed 2017-02-17 | $2.84B derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $829.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $1.56B derived: sum of 2 quarters · filed 2017-02-17 | $2.23B derived: sum of 3 quarters · filed 2017-02-17 | $2.60B 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | $728.00M 10-Q · filed 2015-11-05 | $731.00M 10-Q · filed 2014-11-06 | $1.41B derived: sum of 2 quarters · filed 2015-11-05 | $1.77B 10-Q · filed 2015-11-05 | $1.77B 10-Q · filed 2014-11-06 | $2.40B derived: sum of 4 quarters · filed 2016-02-19 | ||
| 2014-06-30 | $677.00M 10-Q · filed 2015-08-04 | $761.00M 10-Q · filed 2014-08-05 | $1.04B 10-Q · filed 2015-08-04 | $1.21B 10-Q · filed 2014-08-05 | $1.67B derived: sum of 3 quarters · filed 2016-02-19 | $2.14B derived: sum of 4 quarters · filed 2016-02-19 | ||
| 2014-03-31 | $365.00M 10-Q · filed 2015-05-06 | $451.00M 10-Q · filed 2014-05-07 | $993.00M derived: sum of 2 quarters · filed 2016-02-19 | $1.47B derived: sum of 3 quarters · filed 2016-02-19 | $2.09B derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2013-12-31 | $628.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $1.10B derived: sum of 2 quarters · filed 2016-02-19 | $1.73B derived: sum of 3 quarters · filed 2016-02-19 | $2.13B 10-K · filed 2016-02-19 | $2.63B 10-K · filed 2014-02-21 | |||
| 2013-09-30 | $473.00M 10-Q · filed 2014-11-06 | $630.34M 10-Q · filed 2013-11-07 | $1.10B derived: sum of 2 quarters · filed 2014-11-06 | $1.50B 10-Q · filed 2014-11-06 | $1.87B 10-Q · filed 2013-11-07 | $1.69B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $627.00M 10-Q · filed 2014-08-05 | $627.48M 10-Q · filed 2013-08-06 | $1.24B 10-Q · filed 2014-08-05 | $1.24B 10-Q · filed 2013-08-06 | $1.22B derived: sum of 3 quarters · filed 2015-02-27 | $1.53B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $615.00M 10-Q · filed 2014-05-07 | $614.79M 10-Q · filed 2013-05-08 | $591.61M derived: sum of 2 quarters · filed 2015-02-27 | $901.63M derived: sum of 3 quarters · filed 2015-02-27 | $1.47B derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | -$23.39M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $286.63M derived: sum of 2 quarters · filed 2015-02-27 | $850.82M derived: sum of 3 quarters · filed 2015-02-27 | $1.36B 10-K · filed 2015-02-27 | $8.08B 10-K · filed 2013-02-15 | |||
| 2012-09-30 | $310.02M 10-Q · filed 2013-11-07 | $1.99B 10-Q · filed 2012-11-07 | $874.21M derived: sum of 2 quarters · filed 2013-11-07 | $1.38B 10-Q · filed 2013-11-07 | $5.67B 10-Q · filed 2012-11-07 | -$657.09M derived: sum of 4 quarters · filed 2014-02-21 | ||
| 2012-06-30 | $564.19M 10-Q · filed 2013-08-06 | $2.10B 10-Q · filed 2012-08-07 | $1.07B 10-Q · filed 2013-08-06 | $3.68B 10-Q · filed 2012-08-07 | -$967.11M derived: sum of 3 quarters · filed 2014-02-21 | -$372.23M derived: sum of 4 quarters · filed 2014-02-21 | ||
| 2012-03-31 | $509.19M 10-Q · filed 2013-05-08 | $1.58B 10-Q · filed 2012-05-08 | -$1.53B derived: sum of 2 quarters · filed 2014-02-21 | -$936.42M derived: sum of 3 quarters · filed 2014-02-21 | $837.04M derived: sum of 4 quarters · filed 2014-02-21 | |||
| 2011-12-31 | -$2.04B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | -$1.45B derived: sum of 2 quarters · filed 2014-02-21 | $327.85M derived: sum of 3 quarters · filed 2014-02-21 | $1.63B 10-K · filed 2014-02-21 | $5.75B 10-K · filed 2012-02-21 | |||
| 2011-09-30 | $594.88M 10-Q · filed 2012-11-07 | $2.37B derived: sum of 2 quarters · filed 2012-11-07 | $3.67B 10-Q · filed 2012-11-07 | $5.50B derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-06-30 | $1.77B 10-Q · filed 2012-08-07 | $3.07B 10-Q · filed 2012-08-07 | $4.90B derived: sum of 3 quarters · filed 2013-02-15 | $6.09B derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-03-31 | $1.30B 10-Q · filed 2012-05-08 | $3.13B derived: sum of 2 quarters · filed 2013-02-15 | $4.31B derived: sum of 3 quarters · filed 2013-02-15 | $5.92B derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2010-12-31 | $1.83B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $3.01B derived: sum of 2 quarters · filed 2013-02-15 | $4.62B derived: sum of 3 quarters · filed 2013-02-15 | $6.09B 10-K · filed 2013-02-15 | ||||
| 2010-09-30 | $1.18B 10-Q · filed 2011-11-04 | $2.79B derived: sum of 2 quarters · filed 2011-11-04 | $4.26B 10-Q · filed 2011-11-04 | $6.12B derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-06-30 | $1.61B 10-Q · filed 2011-08-04 | $3.08B 10-Q · filed 2011-08-04 | $4.94B derived: sum of 3 quarters · filed 2012-02-21 | $6.58B derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-03-31 | $1.47B 10-Q · filed 2011-05-06 | $3.33B derived: sum of 2 quarters · filed 2012-02-21 | $4.97B derived: sum of 3 quarters · filed 2012-02-21 | $6.65B derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2009-12-31 | $1.86B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $3.50B derived: sum of 2 quarters · filed 2012-02-21 | $5.17B derived: sum of 3 quarters · filed 2012-02-21 | $6.24B 10-K · filed 2012-02-21 | ||||
| 2009-09-30 | $1.64B 10-Q · filed 2010-11-05 | $3.31B derived: sum of 2 quarters · filed 2010-11-05 | $4.37B 10-Q · filed 2010-11-05 | $6.11B derived: sum of 4 quarters · filed 2011-02-18 | ||||
| 2009-06-30 | $1.67B 10-Q · filed 2010-08-05 | $2.73B 10-Q · filed 2010-08-05 | $4.48B derived: sum of 3 quarters · filed 2011-02-18 | $5.87B derived: sum of 4 quarters · filed 2011-02-18 | ||||
| 2009-03-31 | $1.06B 10-Q · filed 2010-05-04 | $2.80B derived: sum of 2 quarters · filed 2011-02-18 | $4.20B derived: sum of 3 quarters · filed 2011-02-18 | $5.61B derived: sum of 4 quarters · filed 2011-02-18 | ||||
| 2008-12-31 | $1.74B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $3.14B derived: sum of 2 quarters · filed 2011-02-18 | $4.55B derived: sum of 3 quarters · filed 2011-02-18 | $5.69B 10-K · filed 2011-02-18 | ||||
| 2008-09-30 | $1.40B 10-Q · filed 2009-11-06 | $2.80B derived: sum of 2 quarters · filed 2009-11-06 | $3.95B 10-Q · filed 2009-11-06 | |||||
| 2008-06-30 | $1.41B 10-Q · filed 2009-08-07 | $2.55B 10-Q · filed 2009-08-07 | ||||||
| 2007-12-31 | $4.58B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |